Literature DB >> 28975390

Clinicopathological features of primary splenic follicular lymphoma.

Joji Shimono1,2, Hiroaki Miyoshi3, Tomohiko Kamimura4, Tetsuya Eto5, Takuto Miyagishima6, Yuya Sasaki1, Daisuke Kurita1, Keisuke Kawamoto1, Koji Nagafuji7, Masao Seto1, Takanori Teshima2, Koichi Ohshima1.   

Abstract

Follicular lymphoma (FL) is a low-grade lymphoma that is usually characterized by generalized lymphadenopathy. Extranodal invasion by FL generally involves the bone marrow, skin, and duodenum; splenic infiltration often occurs in the advanced stages. However, primary splenic FL is very rare. Hence, few studies have been performed on splenic FL, and its clinicopathological features have not been established. This study aimed to investigate the clinicopathological features of primary splenic FL, as compared to nodal FL. We analyzed 17 patients diagnosed with primary splenic FL and 153 control patients with systemic FL. Hepatitis C virus (HCV)-positive status was significantly more common in patients with splenic FL than in the control patients (p = 0.02). Ann Arbor stage III or IV (p = 0.0003) and high-risk FLIPI (Follicular Lymphoma International Prognostic Index) (p = 0.03) were significantly less common in patients with splenic FL than in the control patients; however, the overall and progression-free survival curves were not significantly different between the groups. Among the 17 patients with splenic FL, the progression-free survival was significantly worse in patients who underwent splenectomy without receiving postoperative chemotherapy than in those who did (p = 0.03). These results suggest that primary splenic FL should be considered different from systemic FL; accordingly, its management should also be conducted differently.

Entities:  

Keywords:  Clinicopathological characteristics; Follicular lymphoma; Hepatitis C virus; Prognosis; Splenic lymphoma

Mesh:

Year:  2017        PMID: 28975390     DOI: 10.1007/s00277-017-3139-y

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  4 in total

Review 1.  New developments in the pathology of malignant lymphoma. A review of the literature published from September-August 2017.

Authors:  J H van Krieken
Journal:  J Hematop       Date:  2017-11-29       Impact factor: 0.196

Review 2.  Low-Grade Primary Splenic CD10-Positive Small B-Cell Lymphoma/Follicular Lymphoma.

Authors:  Rami Abdulbaki; Parastou Tizro; Victor E Nava; Maria Gomes da Silva; João L Ascensão
Journal:  Curr Oncol       Date:  2021-11-18       Impact factor: 3.677

3.  Hepatitis C virus infection is an independent prognostic factor in follicular lymphoma.

Authors:  Joji Shimono; Hiroaki Miyoshi; Takeharu Kato; Takeshi Sugio; Kohta Miyawaki; Tomohiko Kamimura; Takuto Miyagishima; Tetsuya Eto; Yoshitaka Imaizumi; Koji Kato; Koji Nagafuji; Koichi Akashi; Masao Seto; Takanori Teshima; Koichi Ohshima
Journal:  Oncotarget       Date:  2017-12-11

Review 4.  The broad landscape of follicular lymphoma: Part II.

Authors:  Stefano Fratoni; Magda Zanelli; Maurizio Zizzo; Francesca Sanguedolce; Valentina Aimola; Giulia Cerrone; Linda Ricci; Alessandra Filosa; Giovanni Martino; Antonella Maria Fara; Valerio Annessi; Alessandra Soriano; Stefano Ascani
Journal:  Pathologica       Date:  2020-03-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.